CYP 6.38% 25.0¢ cynata therapeutics limited

They obviously rejected it as inadequate for the near future...

  1. 35,472 Posts.
    lightbulb Created with Sketch. 2863
    They obviously rejected it as inadequate for the near future prospects...and rightly so in comparison to other deals.
    Stock was around $1.60 and had already been as high as $1.80 prior Sumi, so $2 at time wasn't much of a premium.

    Language from CYP has been quite clear they did not accept $2.
    Sumi didn't walk, they might still be looking and watching developments I'd say.
 
watchlist Created with Sketch. Add CYP (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.